Valuation AFT Pharmaceuticals Limited

Stocks

End-of-day quote New Zealand S.E. 2026-09-29			5-day change	1st Jan Change
4.340 ^NZD	-0.23%		+2.84%	+28.40%

09-08	Aft Pharmaceuticals Limited Partners with Mark Cuban Cost Plus Drug Company to Bring Combogesic to the U.S	CI
07-31	AFT Pharmaceuticals Limited - Shareholder/Analyst Call

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	378	362.8	328.2	282.1	352.4	455.2	-	-
Change	-	-4%	-9.54%	-14.06%	24.91%	29.18%	-	-
Enterprise Value (EV) ¹	407.3	392.7	344.4	296.6	391	485	479.8	475.3
Change	-	-3.57%	-12.3%	-13.89%	31.82%	24.05%	-1.08%	-0.93%
P/E	19x	34.6x	20.9x	24.5x	24x	23.1x	18.3x	17.1x
PBR	6.66x	4.95x	3.74x	2.89x	3.2x	4.97x	4.15x	3.42x
PEG	-	-0.7x	0.4x	-0.9x	0.9x	0.7x	0.7x	2.42x
Capitalization / Revenue	2.9x	2.32x	1.68x	1.36x	1.38x	1.5x	1.32x	1.16x
EV / Revenue	3.13x	2.51x	1.76x	1.43x	1.53x	1.6x	1.39x	1.21x
EV / EBITDA	19x	18.4x	13.1x	14.2x	13.6x	14x	11.6x	9.52x
EV / EBIT	20x	20x	14.2x	16.8x	16x	15.8x	12.9x	10.5x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	0.016	0.018	0.025	0.0328	0.0416	0.0652
Rate of return	-	-	0.51%	0.67%	0.74%	0.75%	0.96%	1.5%
EPS ²	0.19	0.1	0.15	0.11	0.14	0.1878	0.2366	0.2533
Distribution rate	-	-	10.7%	16.4%	17.9%	17.4%	17.6%	25.7%
Net sales ¹	130.3	156.6	195.4	208	254.7	303.8	345.2	392.5
EBITDA ¹	21.43	21.39	26.25	20.88	28.8	34.63	41.41	49.9
EBIT ¹	20.39	19.67	24.24	17.65	24.44	30.64	37.05	45.17
Net income ¹	19.85	10.65	15.61	11.96	14.73	19.7	24.81	26.56
Net Debt ¹	29.3	29.9	16.2	14.5	38.6	29.84	24.6	20.14
Reference price ²	3.610	3.460	3.130	2.690	3.360	4.340	4.340	4.340
Nbr of stocks (in thousands)	104,697	104,866	104,866	104,866	104,866	104,875	-	-
Announcement Date	5/22/22	5/22/23	5/22/24	5/21/25	5/20/26	-	-	-

¹NZD in Million²NZD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
AFT PHARMACEUTICALS LIMITED	23.11x	1.6x	14.01x	0.75%	256M
ELI LILLY AND COMPANY	33.68x	12.2x	24.79x	0.59%	1,056B
JOHNSON & JOHNSON	29.76x	6.61x	18.5x	2%	645B
ABBVIE INC.	33.32x	7.79x	16.11x	2.63%	465B
ROCHE HOLDING AG	19.01x	4.64x	11.49x	2.87%	335B
NOVARTIS AG	20.51x	5.32x	13.17x	3.01%	275B
ASTRAZENECA PLC	20.92x	4.34x	12.36x	2.04%	255B
AMGEN INC.	26.76x	6.95x	12.37x	2.38%	229B
GILEAD SCIENCES, INC.	-45.76x	6.66x	26x	2.18%	188B
NOVO NORDISK A/S	11.27x	4.11x	8.54x	4.46%	169B
Average	17.26x	6.02x	15.73x	2.29%	361.64B
Weighted average by Cap.	24.07x	7.86x	18.08x	1.98%